​
​

Enlivex Therapeutics Ownership | Who Owns Enlivex Therapeutics?

OverviewForecastFinancialsChart

Enlivex Therapeutics Ownership Summary

Enlivex Therapeutics is owned by 11.13% institutional investors, 5.74% insiders, and 83.13% retail investors. Armistice capital is the largest institutional shareholder, holding 9.08% of ENLV shares. Dolphin 90/10 IL is the top mutual fund, with 0.20% of its assets in Enlivex Therapeutics shares.

ENLV Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEnlivex Therapeutics11.13%5.74%83.13%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Dolphin 90/10 IL43.48K0.20%-
MTF TR TA-Growth38.06K0.18%8.57K
IBI Mehaka TA-Growth11.37K0.05%3.37K
Fidelity Nasdaq Composite Index10.42K0.05%-
Dolphin Flexible7.92K0.04%-
I.B.I 90/105.75K0.03%-
Harel HTF TA All-Share IL3.85K0.02%961.00
I.B.I Government + 10% IL3.00K0.01%-
Dolphin75/25 IL787.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 09, 2015Murray Michael Anthony former SVP - OperationsSell$156.76K

ENLV Ownership FAQ

Who Owns Enlivex Therapeutics?

Enlivex Therapeutics shareholders are primarily institutional investors at 11.13%, followed by 5.74% insiders and 83.13% retail investors. The average institutional ownership in Enlivex Therapeutics's industry, Biotech Stocks , is 45.35%, which Enlivex Therapeutics falls below.

Who owns the most shares of Enlivex Therapeutics?

Enlivex Therapeutics’s largest shareholders are Armistice capital (1.7M shares, 9.08%), Morgan stanley (244.89K shares, 1.31%), and Renaissance (71.69K shares, 0.38%). Together, they hold 10.77% of Enlivex Therapeutics’s total shares outstanding.

Does Blackrock own Enlivex Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Enlivex Therapeutics.

Who is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested?

Armistice capital is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 1.7M Enlivex Therapeutics shares, valued at 2.41M$.

Who is the top mutual fund holder of Enlivex Therapeutics shares?

Dolphin 90/10 IL is the top mutual fund holder of Enlivex Therapeutics shares, with 0.20% of its total shares outstanding invested in 43.48K Enlivex Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools